Insider Transactions in Q1 2022 at Protagonist Therapeutics, Inc (PTGX)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 28
2022
|
David Y Liu Chief R&D Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,119
-3.09%
|
$50,856
$24.28 P/Share
|
|
Feb 28
2022
|
Dinesh V Ph D Patel President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,648
-0.91%
|
$111,552
$24.28 P/Share
|
|
Feb 28
2022
|
Suneel Gupta Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
649
-0.84%
|
$15,576
$24.28 P/Share
|
|
Feb 15
2022
|
Dinesh V Ph D Patel President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
31,250
+5.79%
|
-
|
|
Feb 15
2022
|
Suneel Gupta Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+13.86%
|
-
|
|
Feb 15
2022
|
David Y Liu Chief R&D Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+12.71%
|
-
|
|
Feb 15
2022
|
Donald A. Kalkofen Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+28.82%
|
-
|